(Q39826657)

15 September 2017

title

Immunomodulatory cell therapy in sepsis: have we learnt lessons from the past? (English)

1 reference

15 September 2017

0 references

2

1 reference

15 September 2017

Guillaume Monneret

1

1 reference

15 September 2017

publication date

1 October 2010

1 reference

Expert Review of Anti-infective Therapy

15 September 2017

published in

1 reference

15 September 2017

volume

8

1 reference

15 September 2017

issue

10

1 reference

15 September 2017

page(s)

1109-1112

1 reference

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

The pathophysiology and treatment of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

The sepsis seesaw: tilting toward immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Reversal of long-term sepsis-induced immunosuppression by dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Characterization and modulation of the immunosuppressive phase of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

Immunotherapy for sepsis--a new approach against an ancient foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.10.107

21 January 2018

Identifiers

DOI

10.1586/ERI.10.107

1 reference

15 September 2017

1 reference